| Item Type | Name |
|
Concept
|
Diabetes Mellitus, Type 2
|
|
Concept
|
Diabetes Mellitus, Type 1
|
|
Academic Article
|
Recognition and implications of the metabolic syndrome.
|
|
Academic Article
|
Type 2 diabetes: epidemiologic trends, evolving pathogenetic [corrected] concepts, and recent changes in therapeutic approach.
|
|
Academic Article
|
The role of inflammation in diabetes and its complications.
|
|
Academic Article
|
Vitamin D levels in patients seen in the diabetes unit of an academic medical center.
|
|
Academic Article
|
A collaborative approach to the recruitment and retention of minority patients with diabetes in rural community health centers.
|
|
Academic Article
|
Impact of comprehensive diabetes specialty care in the management of older adults with stage 3 or 4 nephropathy.
|
|
Academic Article
|
Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors.
|
|
Academic Article
|
Perioperative management of diabetes and hyperglycemia in patients undergoing orthopaedic surgery.
|
|
Academic Article
|
The risk of developing type 2 diabetes mellitus associated with psychotropic drug use in children and adolescents: a retrospective cohort analysis.
|
|
Academic Article
|
Prevalence and impact of initial misclassification of pediatric type 1 diabetes mellitus.
|
|
Academic Article
|
A review of the cardiovascular and anti-atherogenic effects of ghrelin.
|
|
Academic Article
|
Incretin-based therapies, glucometabolic health and endovascular inflammation.
|
|
Academic Article
|
Diabetic ketoalkalosis in children and adults.
|
|
Academic Article
|
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study.
|
|
Academic Article
|
Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study.
|
|
Academic Article
|
Dapagliflozin therapy in type-2 diabetes: current knowledge and future perspectives.
|
|
Academic Article
|
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study.
|
|
Academic Article
|
Incretins, Pregnancy, and Gestational Diabetes.
|
|
Academic Article
|
The evolving role of bariatric surgery in patients with type 1 diabetes and obesity.
|
|
Academic Article
|
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.
|
|
Academic Article
|
TREATMENT OF TYPE 2 DIABETES WITH BIPHASIC INSULIN ANALOGUES.
|
|
Academic Article
|
Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes.
|
|
Academic Article
|
ADDRESSING HYPERTENSION IN THE PATIENT WITH TYPE 2 DIABETES MELLITUS: PATHOGENESIS, GOALS, AND THERAPEUTIC APPROACH.
|
|
Academic Article
|
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms.
|
|
Academic Article
|
Future perspectives of the pharmacological management of diabetic dyslipidemia.
|
|
Academic Article
|
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study.
|
|
Academic Article
|
Microvascular and macrovascular effects of liraglutide.
|
|
Academic Article
|
Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect.
|
|
Academic Article
|
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect.
|
|
Academic Article
|
Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes.
|
|
Academic Article
|
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes.
|
|
Academic Article
|
Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights.
|
|
Academic Article
|
The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism.
|
|
Academic Article
|
Use of Novel Antidiabetic Agents in Patients with Type?2 Diabetes and COVID-19: A Critical Review.
|
|
Academic Article
|
Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus.
|
|
Academic Article
|
Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies.
|
|
Academic Article
|
Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes.
|
|
Academic Article
|
Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections.
|
|
Academic Article
|
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study.
|
|
Academic Article
|
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes.
|
|
Academic Article
|
Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs - The CAPISCO International Expert Panel.
|
|
Academic Article
|
Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health.
|